Sionna Therapeutics director sells shares worth $9.2 million
NeutralFinancial Markets

The director of Sionna Therapeutics has sold shares valued at $9.2 million, which raises questions about the company's future direction and the director's confidence in its performance. Such transactions can impact investor sentiment and market perception, making it a noteworthy event for stakeholders.
— Curated by the World Pulse Now AI Editorial System